MedPath

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Phase 2
Completed
Conditions
Colorectal Cancer
Interventions
Registration Number
NCT00003254
Lead Sponsor
SWOG Cancer Research Network
Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Ethynyluracil may help fluorouracil kill more cancer cells by making tumor cells more sensitive to the drug.

PURPOSE: Phase II trial to study the effectiveness of fluorouracil plus ethynyluracil in treating patients with advanced colorectal cancer that has not responded to fluorouracil.

Detailed Description

OBJECTIVES: I. Assess the confirmed response rate to fluorouracil (5-FU) plus ethynyluracil (776C85) in patients with metastatic colorectal cancer that has been demonstrated to be resistant to 5-FU. II. Assess time to progression and survival in this group of patients. III. Assess the frequency and severity of toxicities associated with this treatment.

OUTLINE: Patients are stratified according to relapse while receiving adjuvant therapy (relapse within 12 months of completing adjuvant therapy vs relapse while receiving adjuvant therapy). Patients receive oral doses of ethynyluracil (776C85) and fluorouracil twice daily for 28 days followed by 1 week of rest. Treatment continues every 5 weeks in the absence of disease progression or unacceptable toxicity. Patients are followed every 3 months the first year, every 4 months the second year, and every 6 months thereafter.

PROJECTED ACCRUAL: A total of 35-75 patients will be accrued for this study.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
75
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
776C85 + 5-FUethynyluracil776C85, 10mg/m2/dose, PO, Days 1-28 (BID), q 5 wk; 5-FU, 1.0mg/m2/dose, PO, Days 1-28 (BID), q 5 wk.
776C85 + 5-FUfluorouracil776C85, 10mg/m2/dose, PO, Days 1-28 (BID), q 5 wk; 5-FU, 1.0mg/m2/dose, PO, Days 1-28 (BID), q 5 wk.
Primary Outcome Measures
NameTimeMethod
Confirmed Response RateOnce every 10 weeks until off treatment

To assess the confirmed response rate to 5-fluorouracil plus 776C85 in patients with measurable, disseminated colorectal cancer that has been demonstrated to be resistant to 5-fluorouracil.

Secondary Outcome Measures
NameTimeMethod
Progression and SurvivalOnce every 10 weeks until progression

To assess time to progression and survival in this group of patients.

ToxicitiesOnce each week during treatment

To assess the frequency and severity of toxicities associated with this treatment.

Trial Locations

Locations (86)

USC/Norris Comprehensive Cancer Center

🇺🇸

Los Angeles, California, United States

CCOP - Dayton

🇺🇸

Kettering, Ohio, United States

University of Texas Medical Branch

🇺🇸

Galveston, Texas, United States

CCOP - Virginia Mason Research Center

🇺🇸

Seattle, Washington, United States

Veterans Affairs Medical Center - Seattle

🇺🇸

Seattle, Washington, United States

Barrett Cancer Center, The University Hospital

🇺🇸

Cincinnati, Ohio, United States

Veterans Affairs Medical Center - Cincinnati

🇺🇸

Cincinnati, Ohio, United States

University of Texas Health Science Center at San Antonio

🇺🇸

San Antonio, Texas, United States

UCSF Cancer Center and Cancer Research Institute

🇺🇸

San Francisco, California, United States

Veterans Affairs Medical Center - Salt Lake City

🇺🇸

Salt Lake City, Utah, United States

University of Mississippi Medical Center

🇺🇸

Jackson, Mississippi, United States

CCOP - Greater Phoenix

🇺🇸

Phoenix, Arizona, United States

Veterans Affairs Medical Center - Detroit

🇺🇸

Detroit, Michigan, United States

Barbara Ann Karmanos Cancer Institute

🇺🇸

Detroit, Michigan, United States

Veterans Affairs Medical Center - Oklahoma City

🇺🇸

Oklahoma City, Oklahoma, United States

Beckman Research Institute, City of Hope

🇺🇸

Los Angeles, California, United States

CCOP - Atlanta Regional

🇺🇸

Atlanta, Georgia, United States

CCOP - Central Illinois

🇺🇸

Decatur, Illinois, United States

Veterans Affairs Medical Center - Long Beach

🇺🇸

Long Beach, California, United States

Arizona Cancer Center

🇺🇸

Tucson, Arizona, United States

Cleveland Clinic Cancer Center

🇺🇸

Cleveland, Ohio, United States

CCOP - Montana Cancer Consortium

🇺🇸

Billings, Montana, United States

Keesler Medical Center - Keesler AFB

🇺🇸

Keesler AFB, Mississippi, United States

CCOP - Bay Area Tumor Institute

🇺🇸

Oakland, California, United States

Chao Family Comprehensive Cancer Center

🇺🇸

Orange, California, United States

CCOP - Santa Rosa Memorial Hospital

🇺🇸

Santa Rosa, California, United States

David Grant Medical Center

🇺🇸

Travis Air Force Base, California, United States

MBCCOP - University of South Alabama

🇺🇸

Mobile, Alabama, United States

Veterans Affairs Medical Center - Little Rock (McClellan)

🇺🇸

Little Rock, Arkansas, United States

MBCCOP - University of New Mexico HSC

🇺🇸

Albuquerque, New Mexico, United States

Veterans Affairs Medical Center - Wichita

🇺🇸

Wichita, Kansas, United States

Veterans Affairs Medical Center - Lexington

🇺🇸

Lexington, Kentucky, United States

Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital)

🇺🇸

Hines, Illinois, United States

Dwight David Eisenhower Army Medical Center

🇺🇸

Fort Gordon, Georgia, United States

Cancer Research Center of Hawaii

🇺🇸

Honolulu, Hawaii, United States

Henry Ford Hospital

🇺🇸

Detroit, Michigan, United States

Tripler Army Medical Center

🇺🇸

Honolulu, Hawaii, United States

CCOP - Wichita

🇺🇸

Wichita, Kansas, United States

Oklahoma Medical Research Foundation

🇺🇸

Oklahoma City, Oklahoma, United States

Brooke Army Medical Center

🇺🇸

Fort Sam Houston, Texas, United States

Simmons Cancer Center - Dallas

🇺🇸

Dallas, Texas, United States

Albert B. Chandler Medical Center, University of Kentucky

🇺🇸

Lexington, Kentucky, United States

Boston Medical Center

🇺🇸

Boston, Massachusetts, United States

Veterans Affairs Medical Center - Biloxi

🇺🇸

Biloxi, Mississippi, United States

Herbert Irving Comprehensive Cancer Center

🇺🇸

New York, New York, United States

St. Louis University Health Sciences Center

🇺🇸

Saint Louis, Missouri, United States

Veterans Affairs Medical Center - Denver

🇺🇸

Denver, Colorado, United States

University of Colorado Cancer Center

🇺🇸

Denver, Colorado, United States

Oregon Cancer Center at Oregon Health Sciences University

🇺🇸

Portland, Oregon, United States

Veterans Affairs Medical Center - Portland

🇺🇸

Portland, Oregon, United States

CCOP - St. Louis-Cape Girardeau

🇺🇸

Saint Louis, Missouri, United States

Veterans Affairs Medical Center - Tucson

🇺🇸

Tucson, Arizona, United States

Veterans Affairs Medical Center - Phoenix (Hayden)

🇺🇸

Phoenix, Arizona, United States

University of Arkansas for Medical Sciences

🇺🇸

Little Rock, Arkansas, United States

Veterans Affairs Medical Center - New Orleans

🇺🇸

New Orleans, Louisiana, United States

Veterans Affairs Medical Center - Brooklyn

🇺🇸

Brooklyn, New York, United States

Veterans Affairs Medical Center - Dayton

🇺🇸

Dayton, Ohio, United States

Veterans Affairs Medical Center - Temple

🇺🇸

Temple, Texas, United States

Veterans Affairs Medical Center - San Antonio (Murphy)

🇺🇸

San Antonio, Texas, United States

CCOP - Scott and White Hospital

🇺🇸

Temple, Texas, United States

Huntsman Cancer Institute

🇺🇸

Salt Lake City, Utah, United States

CCOP - Northwest

🇺🇸

Tacoma, Washington, United States

Jonsson Comprehensive Cancer Center, UCLA

🇺🇸

Los Angeles, California, United States

Loyola University Medical Center

🇺🇸

Maywood, Illinois, United States

Tulane University School of Medicine

🇺🇸

New Orleans, Louisiana, United States

Veterans Affairs Medical Center - Jackson

🇺🇸

Jackson, Mississippi, United States

CCOP - Kansas City

🇺🇸

Kansas City, Missouri, United States

MBCCOP - LSU Medical Center

🇺🇸

New Orleans, Louisiana, United States

Louisiana State University Health Sciences Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Veterans Affairs Medical Center - Shreveport

🇺🇸

Shreveport, Louisiana, United States

Providence Hospital - Southfield

🇺🇸

Southfield, Michigan, United States

Veterans Affairs Medical Center - Boston (Jamaica Plain)

🇺🇸

Jamaica Plain, Massachusetts, United States

Veterans Affairs Medical Center - Ann Arbor

🇺🇸

Ann Arbor, Michigan, United States

Veterans Affairs Medical Center - Kansas City

🇺🇸

Kansas City, Missouri, United States

CCOP - Grand Rapids Clinical Oncology Program

🇺🇸

Grand Rapids, Michigan, United States

CCOP - Cancer Research for the Ozarks

🇺🇸

Springfield, Missouri, United States

CCOP - Columbia River Program

🇺🇸

Portland, Oregon, United States

Veterans Affairs Medical Center - Albuquerque

🇺🇸

Albuquerque, New Mexico, United States

CCOP - Greenville

🇺🇸

Greenville, South Carolina, United States

CCOP - Columbus

🇺🇸

Columbus, Ohio, United States

Texas Tech University Health Science Center

🇺🇸

Lubbock, Texas, United States

CCOP - Upstate Carolina

🇺🇸

Spartanburg, South Carolina, United States

Swedish Cancer Institute

🇺🇸

Seattle, Washington, United States

University of California Davis Medical Center

🇺🇸

Sacramento, California, United States

University of Michigan Comprehensive Cancer Center

🇺🇸

Ann Arbor, Michigan, United States

University of Kansas Medical Center

🇺🇸

Kansas City, Kansas, United States

© Copyright 2025. All Rights Reserved by MedPath